Workshop on Intellectual Property, Health Care and International Trade Agreements

May 7-8, 1998
Capital Room
Hotel Washington
Washington, DC

Thursday, May 7

9:00 AM Opening Remarks by Ralph Nader and Introduction of participants

9:30 AM Overview of Intellectual Property Issues and Public Interest Considerations, as they relate to public health

Public Health and Research and Development
What are the available Mechanisms to Finance R&D?
Who makes policy?

10:30 AM Break

10:45 AM Discussion of specific IPR disputes

Patent Disputes
Parallel imports
Counterfeit drugs
Scope of patents in health care
Standards for patent protection
Second use patents, evergreening of patents, and related issues
Bolar provisions and other exemptions for medical research
Patent terms and patent extensions
Compulsory licensing
Non-Patent Issues
Health Registration Data
"unfair competition" protections
Orphan Drugs subsides
exclusive marketing rights
Sui Generis Database Legislation
Trademarks and Public Health
generic drugs
infant formula


12:00 PM Break for Lunch in Area Restaurants


1:30 PM Continue Discussion of Specific IPR disputes

3:30 PM Break

3:45 PM Continue Discussion of Specific IPR disputes

5:30 PM Conclusion of First Day

Friday, May 8

9:AM PM Continue Discussion of Specific IPR disputes

10:00 AM Economics of Drug Development

What does it really cost to develop new drugs?
Pricing of Government Funded Medical Inventions
Need to collect economic data

11:00 AM Break

11:15 AM WHO Resolution on Revised Drug Policy

12:00- 1:30 PM Lunch in area restaurants

1:30 PM Dialog with U.S. Government Policy Makers

3:00 PM Break

3:15 PM How do consumer and public health advocates

Organize? Next Steps

5:00 PM Concluding Comments

5:30 PM Conclusion



For more information, see

Return to [Workshop Page] | [CPT Home Page] | [CPT Health Care Page]
This page has been accessed  times since May 4, 1998